Navigation Links
In Vitro Diagnostics (IVD) - Emerging Countries (Brazil, Russia, India, China) Opportunity Assessment, Competitive Landscape and Market Forecasts to 2018
Date:7/24/2012

s (Brazil, Russia, India and China), Company Shares (%), 2011 23
4.3.1 In Vitro Diagnostics Market, China, Company Share (%), 2011 23
4.3.2 In Vitro Diagnostics Market, India, Company Share (%), 2011 24
4.3.3 In Vitro Diagnostics Market, Brazil, Company Share (%), 2011 25
4.3.4 In Vitro Diagnostics Market, Russia, Company Share (%), 2011 26
4.4 In Vitro Diagnostics Market, Emerging Countries, Key Trends 27
4.4.1 Development of Point of Care Testing Specific to Emerging Countries 27
4.4.2 Consolidation of IVD Market in Emerging Countries through Acquisition of Local Companies by Multi National IVD Companies 28
4.5 In Vitro Diagnostics, Emerging Countries (Brazil, Russia, India and China): Market Dynamics 29
4.5.1 Market Drivers 30
4.5.2 Market Restraints 36
5 In Vitro Diagnostics, Emerging Countries - Category Analysis 38
5.1 Immunochemistry 38
5.2 Immunochemistry Market, Emerging Countries, Revenue ($m), 2004-2018 39
5.2.1 Immunochemistry Market, China, Revenue ($m), Historic, 2004-2011 39
5.2.2 Immunochemistry Market, China, Revenue ($m), Forecast, 2011-2018 40
5.2.3 Immunochemistry Market, India, Revenue ($m), Historic, 2004-2011 41
5.2.4 Immunochemistry Market, India, Revenue ($m), Forecast, 2011-2018 42
5.2.5 Immunochemistry Market, Brazil, Revenue ($m), Historic, 2004-2011 43
5.2.6 Immunochemistry Market, Brazil, Revenue ($m), Forecast, 2011-2018 44
5.2.7 Immunochemistry Market, Russia, Revenue ($m), Historic, 2004-2011 45
5.2.8 Immunochemistry Market, Russia, Revenue ($m), Forecast, 2011-2018 46
5.3 Immunochemistry Market, Emerging Countries (Brazil, Russia, India and China), Company Shares (%), 2011 47
5.3.1 Immunochemistry Market, China, Company Share (%), 2011 47
5.3.2 Immunochemistry Market, India, Company Share (%), 2011 48
5.3.3 Immunochemistry Market, Brazil, Company Share (%), 2011 49
5.3.4 Immunochemistry Market, Russia, Company Share (%), 2011 50'/>"/>
SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20

Related biology technology :

1. Auxogyn And Reproductive Medicine Associates of New Jersey Partner To Advance in vitro fertilization Research
2. MultiCell Technologies Announces Positive Preclinical Results for MCT-465 and MCT-485 in Primary Liver Cancer In Vitro Models
3. India In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture
4. Pittsburgh Based ParentPlus Enters Collaboration with Vitrolife
5. Frost & Sullivan Presents 2012 Clinical Diagnostics Company of the Year Award to GenPath Diagnostics of BioReference Laboratories, Inc.
6. Comprehensive Resource for Food Safety Diagnostics – Romer Labs Launches New Website
7. NextGen introduces its first generation of animal biomarker products for development of brain disorder diagnostics
8. QuantRx® Biomedical Provides Corporate Update: Focused on Diagnostics and Feminine Hygiene Segments
9. Exosome Diagnostics Presents Data at American Urology Association Demonstrating Potential Utility of Urine Exosomes to Non-invasively Detect and Manage Prostate Cancer
10. Ariosa Diagnostics Announces Publication of Study on Influential Factors Affecting Fetal DNA Concentration in Blood of Pregnant Women
11. Ariosa Diagnostics Announces Nationwide Launch of the Harmony™ Prenatal Test Through LabCorp
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... , ... July 01, 2015 , ... It is now ... (TBI) using single photon emission computed tomography (SPECT) according to researchers from ... which examined over 20,000 brain scans and is believed to be the largest brain ...
(Date:7/1/2015)... Mass. , July 1, 2015   ... most frequently cited advantages of Otezla are its ... safety profile, as reported by surveyed rheumatologists. Otezla ... launched for the treatment of active psoriatic arthritis ... The current standard of care includes conventional oral ...
(Date:7/1/2015)... and BANGALORE, India , July 1, ... company that uses next generation sequencing technology to empower ... A. Storrer as chief executive officer. In his ... be responsible for all strategy, business expansion and worldwide ... has served as Strand,s chairman and CEO since its ...
(Date:7/1/2015)...  Axovant Sciences Ltd. (NYSE:  AXON), a leading ... dementia, today announced that the company will host ... p.m. EDT following its presentation of RVT-101 clinical ... (AAIC). The event will include ... Lawrence Friedhoff , Chief Development Officer, will present ...
Breaking Biology Technology:Brain Scans Can Tell Post-Traumatic Stress Disorder and Traumatic Brain Injury Apart According to New Research by Amen Clinics 2Brain Scans Can Tell Post-Traumatic Stress Disorder and Traumatic Brain Injury Apart According to New Research by Amen Clinics 3Brain Scans Can Tell Post-Traumatic Stress Disorder and Traumatic Brain Injury Apart According to New Research by Amen Clinics 4Surveyed Rheumatologists Report That Otezla's Oral Administration is its Single Greatest Advantage Over Currently Available Treatment Options 2Surveyed Rheumatologists Report That Otezla's Oral Administration is its Single Greatest Advantage Over Currently Available Treatment Options 3Strand Life Sciences Names Scott A. Storrer CEO as Company Continues Global Expansion with Focus on Precision Medicine Product 2Strand Life Sciences Names Scott A. Storrer CEO as Company Continues Global Expansion with Focus on Precision Medicine Product 3Axovant Sciences To Host Investor Briefing And Live Webcast During AAIC 2015 Meeting 2Axovant Sciences To Host Investor Briefing And Live Webcast During AAIC 2015 Meeting 3
... in reconstructive and aesthetic plastic surgeryMEDFORD, Mass., ... growth-stage medical device company developing silk-based biomaterial ... has received 510(k) clearance from the U.S. ... SeriScaffold (TM) silk-based, long term bioresorbable ...
... /PRNewswire/ - ImmunoVaccine Technologies Inc. (IVT), a vaccine ... the National Institute of Allergy and Infectious Diseases ... in Maryland, USA. The research collaboration involves formulating ... and exploring potential vaccines for HIV and malaria. ...
... its financial results for the year ending 31,December 2008. , , ... process for intravenous iclaprim in US, - Restructuring ... "intravenous-to-oral" Phase II trial with oral, ... - Share placing, Cash and financial investments of CHF ...
Cached Biology Technology:Serica Technologies Receives FDA 510(k) Clearance for SeriScaffold(TM) Technology for Soft Tissue Repair 2Serica Technologies Receives FDA 510(k) Clearance for SeriScaffold(TM) Technology for Soft Tissue Repair 3Serica Technologies Receives FDA 510(k) Clearance for SeriScaffold(TM) Technology for Soft Tissue Repair 4ImmunoVaccine Technologies Signs Agreement with National Institutes of Health to Explore Vaccines for HIV and Malaria 2Arpida Announces Full Year 2008 Financial Results 2Arpida Announces Full Year 2008 Financial Results 3Arpida Announces Full Year 2008 Financial Results 4Arpida Announces Full Year 2008 Financial Results 5
(Date:6/29/2015)... June 24, 2015 Research ... the "Latin America Biomedical Sensors Market - Growth, ... The Latin America Biomedical Sensors market is ... of 2.04% over the period 2014-2020 The ... to the genetic formulation of each individual. These sensors ...
(Date:6/25/2015)... 2015 According to a ... & Area), Technology, Material (Optical Prism, Piezoelectric, Capacitive ... & Others) & Geography - Global Forecast to ... market is expected to reach $14,500.07 Million by ... Browse 76 market Tables and 109 Figures ...
(Date:6/25/2015)... 2015  TAKE Solutions Ltd., a global business technology ... States Patent and Trademark Office (USPTO) for its "Method ... Solutions, Clinical Accelerators to reduce the time taken to ... standardization without the accelerators), thus reducing time to market. ... At the heart of the patented Clinical Data Standardization ...
Breaking Biology News(10 mins):Latin America Biomedical Sensors Market Report 2015-2020 2Fingerprint Sensors Market Worth $14,500.07 Million by 2020 2Fingerprint Sensors Market Worth $14,500.07 Million by 2020 3Fingerprint Sensors Market Worth $14,500.07 Million by 2020 4TAKE Solutions Awarded Patent By USPTO 2
... , This release is available in German ... at the Max Planck Institute for Molecular Biomedicine in Mnster ... defined cell type from the testis of adult mice and ... viruses or reprogramming proteins. These stem cells have the capacity ...
... Orleans, LA Jay K. Kolls, MD, Professor and Chairman ... of Medicine, has been awarded $1.8 million over five years ... National Institutes of Health to study whether antibodies that recognize ... that causes Pneumocystis carinii pneumonia (PCP) can be ...
... yourself with a blanket to stave off the shivers? ... help alleviate shivering in patients who have been cooled ... or dangerously high fevers are often cooled to reduce ... aid healing. Unfortunately, cooling induces a natural and familiar ...
Cached Biology News:Playing it safe 2Playing it safe 3
[5,6,8,9,12,14,15(n)-3H]Prostaglandin D2, 925 kBq, 25 uCi. Methanol:water:acetonitrile (3:2:1) solution.> 3.0 TBq/mmol, > 80 Ci/mmol.3.7 MBq/ml, 100 uCi/ml. Category: Radiochemicals &Radiation Safety...
EnzChek cellulase substrate *blue fluorescent, 339/452...
Request Info...
Rubeola (Measles) Antigen Preservative: No Preservatives...
Biology Products: